一个多式深度学习架构,用于预测间歇性葡萄糖,以有效管理2型糖尿病
Muhammad Salman Haleem1,2, Daphne Katsarou3, Eleni I Georga3
1School of Engineering, University of Warwick, Coventry, CV4 7AL, UK. salman.haleem@warwick.ac.uk.
Scientific reports
|July 29, 2025
概括
这项研究引入了一种多式深度学习模型,用于预测2型糖尿病患者的葡萄糖水平,将持续葡萄糖监测 (CGM) 数据与健康记录集成,以提高准确性. 这种新方法提高了个性化糖尿病管理,比以前的方法更有效地预测葡萄糖的变化.
科学领域:
- 生物医学工程 生物医学工程
- 医疗保健中的人工智能
- 内分泌学 在内分泌学.
背景情况:
- 准确的血糖预测对于糖尿病管理至关重要.
- 持续葡萄糖监测 (CGM) 提供实时数据,但预测葡萄糖变化仍然具有挑战性.
- 现有的深度学习模型通常使用单模输入,忽视个体生理差异.
研究的目的:
- 开发一种多式深度学习方法,用于在2型糖尿病中进行间歇性葡萄糖预测.
- 将CGM数据与健康记录中的个性化生理信息进行整合.
- 提高葡萄糖预测模型的准确性和通用性.
主要方法:
- 一个多式深度学习架构,将卷积神经网络 (CNN) 和双向长短期记忆 (BiLSTM) 结合起来,用于CGM时间序列.
- 一个独立的神经网络管道处理了基线健康记录以捕捉生理异质性.
- 合并CGM和健康记录数据流,以提高预测.
- 使用5分钟的滑动窗口,预测CGM值在15分,30分和60分钟的时间范围内.
主要成果:
- 多式联网模型在整个预测视野中实现了Abbot传感器的6-18 mg/dL和Menarini传感器的14-26 mg/dL之间的平均绝对点误差 (MAPE).
- 预测准确度达到了96.7%.
- 与单模方法相比,多模方法显示出更高的预测准确性.
结论:
- 拟议的多式模式通过将CGM数据与个人健康记录相结合,有效地预测间歇性葡萄糖水平.
- 这种方法为2型糖尿病的个性化葡萄糖管理提供了更准确和更普遍的解决方案.
- 这些发现支持多式联络深度学习在主动糖尿病护理方面的潜力.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes: Management and Pharmacotherapy
393
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
393
Glucagon-like Receptor Agonists
420
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
420
Hormones Regulating Blood Glucose
4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K


